FDA label
What is Eysuvis used for?
Eysuvis contains loteprednol etabonate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Eysuvis?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Eysuvis, suspension/ drops
Indications and Usage, quoted from the label by ALCON LABORATORIES, INC. (NDA210933). Cross-references to other label sections are left out.
EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
Source: DailyMed label, set id a2169d82-4275-4ab6-a1c3-c274080b815c, version 10, effective March 11, 2025. NDC 71571-333, one of 1 listing for this product.
Questions
What is Eysuvis used for?
The FDA label says: “EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.”
What drug class is Eysuvis?
FDA lists loteprednol etabonate in the Corticosteroid established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Eysuvis
- Is Eysuvis a controlled substance?Federal schedule
- Generic for EysuvisFDA Orange Book
- What is Loteprednol Etabonate used for?FDA label uses
- Is Loteprednol Etabonate a controlled substance?Federal schedule
- Generic for LotemaxFDA Orange Book
- Generic for Lotemax SMFDA Orange Book
- Generic for AlrexFDA Orange Book
- Generic for InveltysFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 71571-333Eysuvis NDC record